The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Patel Sujal M since 2021.
This trader's CIK number is 1378830.
At the time of last reporting, Patel Sujal M was the CEO, President, and Secretary of Nautilus Biotechnology, Inc.. (stock ticker symbol NAUT).
Also see all insider trading activities at Nautilus Biotechnology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | NAUT | 25,000 | $65,250 | 0 | $0 | 0 | $0 |
| 2025 | NAUT | 277,233 | $212,469 | 0 | $0 | 0 | $0 |
| 2024 | NAUT | 50,000 | $140,534 | 0 | $0 | 0 | $0 |
| 2022 | NAUT | 150,000 | $523,974 | 0 | $0 | 100 | $1,000 |
| 2021 | NAUT | 250,000 | $1,181,292 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-04 | NAUT | Buy | 25,000 | 2.61 | 65,250 |
| 2025-09-05 | NAUT | Buy | 116,500 | .67 | 78,521 |
| 2025-09-08 | NAUT | Buy | 83,500 | .68 | 57,030 |
| 2025-03-19 | NAUT | Buy | 53,300 | .99 | 53,033 |
| 2025-03-20 | NAUT | Buy | 23,933 | 1.00 | 23,885 |
| 2024-03-08 | NAUT | Buy | 2,430 | 2.99 | 7,263 |
| 2024-03-11 | NAUT | Buy | 12,044 | 2.84 | 34,217 |
| 2024-03-05 | NAUT | Buy | 7,405 | 2.65 | 19,593 |
| 2024-03-06 | NAUT | Buy | 9,267 | 2.70 | 25,030 |
| 2024-03-07 | NAUT | Buy | 18,854 | 2.89 | 54,431 |
| 2022-08-05 | NAUT | Buy | 41,654 | 2.92 | 121,629 |
| 2022-08-08 | NAUT | Buy | 8,346 | 2.93 | 24,445 |
| 2022-05-09 | NAUT | Buy | 50,000 | 3.96 | 198,000 |
| 2022-03-03 | NAUT | Buy | 50,000 | 3.60 | 179,900 |
| 2022-03-04 | NAUT | Option Ex | 100 | 10.00 | 1,000 |
| 2021-12-01 | NAUT | Buy | 88,022 | 4.73 | 416,432 |
| 2021-11-30 | NAUT | Buy | 161,978 | 4.72 | 764,860 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patel Sujal M (CEO, President, and Secretary of Nautilus Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.